Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension [Phase 2]
Phase 2 trial assessing MLS-101 for uncontrolled hypertension with renal involvement completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease [Phase 2]
A Phase 2 study evaluating AZD5718 in proteinuric chronic kidney disease was terminated; results have been posted.
-
FDA approval · 2023-12-22FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Improving Chronic Disease Management With Pieces [NA]
Completed clinical trial evaluating a program for improving chronic disease management in chronic kidney disease and diabetes.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Metformin as RenoProtector of Progressive Kidney Disease [Phase 3]
Phase 3 clinical trial investigating metformin as a RenoProtector for progressive chronic kidney disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-12-12FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) from Takeda Pharmaceuticals America, Inc., resulting in changes t…
-
FDA approval · 2023-12-06FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for lanthanum carbonate (Cipla USA Inc.). This action updates the product's regulatory approval stat…
-
FDA approval · 2023-10-17FDA Approved: XPHOZAH 10 MG — Original Application (Ardelyx, Inc.)
FDA approved XPHOZAH (tenapanor) from Ardelyx in its original NDA for the treatment of hyperphosphatemia in adults with chronic kidney disea…
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease [Phase 3]
Phase 3 trial investigating SZC for effects on serum potassium and bicarbonate in patients with hyperkalemia and metabolic acidosis related …
-
FDA approval · 2023-10-02FDA Approved: VELTASSA — Supplemental Application (Vifor Pharma, Inc.)
FDA approved a supplemental application for VELTASSA (patiromer) submitted by Vifor Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Berinert (C1INH) vs Placebo for DGF/IRI [Phase 1, Phase 2]
Phase 1/2 clinical trial comparing Berinert (C1 esterase inhibitor) to placebo for delayed graft function and ischemia-reperfusion injury; t…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract [Phase 3]
Phase 3 clinical trial update on antibiotic prophylaxis and renal damage in congenital abnormalities of the kidney and urinary tract; status…
-
EMA approval · 2023-09-27EMA Authorised: Eporatio (epoetin theta) — Ratiopharm GmbH
Authorised status for Eporatio (epoetin theta) by Ratiopharm GmbH for treatment areas including chronic kidney failure, anemia, and cancer.
-
EMA approval · 2023-09-27EMA Authorised: Biopoin (epoetin theta) — Teva GmbH
Biopoin (epoetin theta) has been authorised by the EMA for indications including chronic kidney failure, anemia, and cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-25Clinical Trial Update: Dietary Acid Load, Kidney Function and Disability in Elderly [NA]
Completed clinical trial investigating dietary acid load, kidney function, and disability in elderly with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease [NA]
A completed clinical trial evaluating the effect of lanthanum carbonate on FGF23 levels in chronic kidney disease.
-
FDA approval · 2023-09-08FDA Approved: SEVELAMER CARBONATE — Original Application (Strides Pharma Science Limited)
FDA approved the original abbreviated new drug application for sevelamer carbonate from Strides Pharma Science Limited, a generic phosphate …
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Effects of Remote Patient Monitoring on Chronic Disease Management [NA]
Completed clinical trial examining the impact of remote patient monitoring on management of chronic diseases with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus [Phase 4]
A Phase 4 trial analyzed how chronic kidney disease affects clopidogrel in patients with type 2 diabetes, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease [Phase 3]
Phase 3 trial assessing vitamin D repletion in vitamin D deficient patients with stage 3-4 chronic kidney disease; results posted after comp…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Spironolactone in CKD Enabled by Chlorthalidone: PILOT [Phase 2]
A Phase 2 trial update for Spironolactone in chronic kidney disease enabled by chlorthalidone (PILOT).
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition [Phase 2]
Phase 2 trial evaluating whether an antibody-mediated IL-6 inhibition reduces inflammation in patients with advanced chronic kidney disease.…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Vascular Risk After Kidney Transplantation
Clinical trial update reporting vascular risk after kidney transplantation with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease [Phase 4]
Phase 4 trial evaluating denosumab on bone and vascular metabolism in osteoporotic chronic kidney disease; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease [Phase 2]
Phase 2 trial investigating eGFR slope as a risk marker for rapid kidney function decline in chronic kidney disease; study terminated with r…